Proteasome inhibition prevents experimentally-induced endothelial dysfunction.

Area of Science:

• Vascular Biology
• Endothelial Function
• Proteasome Inhibition

Background:

• Proteasome inhibition upregulates antioxidative enzymes and adaptive transcriptional patterns in endothelial cells.
• Previous studies show conflicting data on proteasome inhibition's effects on endothelial function.
• This study investigates proteasome inhibition's potential to prevent experimentally induced endothelial dysfunction.

Purpose of the Study:

• To determine if proteasome inhibition can prevent tumor necrosis factor-alpha (TNFα)-induced endothelial dysfunction.
• To investigate the molecular mechanisms underlying proteasome inhibition's effects on vascular function.

Main Methods:

• Endothelial dysfunction was induced in rat aortic rings using TNFα.
• Rings were co-treated with proteasome inhibitors (MG132) and TNFα.
• Evaluated vasorelaxation, gene expression (eNOS, NADPH oxidase, SOD1), and superoxide production.

Main Results:

• TNFα significantly reduced acetylcholine-induced vasorelaxation.
• MG132 co-treatment dose-dependently improved vasorelaxation compared to TNFα alone.
• MG132 suppressed NADPH oxidase, increased SOD1, reduced superoxide production, and abolished TNFα-induced endothelin upregulation.
• eNOS mRNA and protein levels decreased despite improved vascular function.

Conclusions:

• Proteasome inhibition prevents TNFα-induced vascular dysfunction.
• This protective effect is mediated by reduced superoxide production and endothelin levels.
• Proteasome inhibition favors endothelium-dependent vasodilation, improving vascular homeostasis.